|
gptkbp:instanceOf
|
Psychoactive drug
|
|
gptkbp:affects
|
gptkb:Perception
emotion
Cognition
|
|
gptkbp:alsoKnownAs
|
Psychedelics
|
|
gptkbp:category
|
gptkb:Classical_hallucinogens
gptkb:Deliriant_hallucinogens
gptkb:Dissociative_hallucinogens
|
|
gptkbp:cause
|
gptkb:Nausea
gptkb:Anxiety
gptkb:Synesthesia
gptkb:Flashbacks
gptkb:Hallucinations
gptkb:Paranoia
gptkb:HPPD
Sweating
Increased heart rate
Loss of appetite
Dilated pupils
Spiritual experiences
Altered sense of time
|
|
gptkbp:discoveredBy
|
Ancient times
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hallucinogens
|
|
gptkbp:include
|
gptkb:PCP
gptkb:Salvia_divinorum
gptkb:Mescaline
gptkb:Ketamine
gptkb:Psilocybin
gptkb:DOM
gptkb:DMT
gptkb:Ayahuasca
gptkb:DXM
gptkb:2C-B
gptkb:Ibogaine
LSD
Peyote
|
|
gptkbp:legalStatus
|
Varies by country
|
|
gptkbp:mechanismOfAction
|
NMDA receptor antagonism
Kappa opioid receptor agonism
Serotonin receptor agonism
|
|
gptkbp:notableExample
|
Albert Hofmann (LSD discovery)
|
|
gptkbp:relatedTo
|
gptkb:Psychedelic_therapy
Drug policy
Entheogen
|
|
gptkbp:studiedBy
|
gptkb:pharmacy
gptkb:Psychiatry
Neuroscience
|
|
gptkbp:usedFor
|
gptkb:psychotherapy
Religious rituals
Spiritual practices
Recreational purposes
|
|
gptkbp:bfsParent
|
gptkb:Schedule_I_(US)
|
|
gptkbp:bfsLayer
|
6
|